CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
74.86
-1.00 (-1.32%)
Sep 2, 2026, 10:59 AM EDT - Market open
CG Oncology Employees
CG Oncology had 142 employees as of December 31, 2025. The number of employees increased by 29 or 25.66% compared to the previous year.
Employees
142
Change (1Y)
29
Growth (1Y)
25.66%
Revenue / Employee
$43,859
Profits / Employee
-$1,580,106
Market Cap
6.64B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 142 | 29 | 25.66% |
| Dec 31, 2024 | 113 | 52 | 85.25% |
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| Rhythm Pharmaceuticals | 414 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| Erasca | 103 |
CGON News
- 3 hours ago - CG Oncology to Present at Upcoming Investor Conferences in September - GlobeNewsWire
- 26 days ago - CG Oncology price target raised to $85 from $82 at Truist - TheFly
- 26 days ago - CG Oncology price target lowered to $79 from $81 at RBC Capital - TheFly
- 27 days ago - CG Oncology reports Q2 EPS (90c), consensus (64c) - TheFly
- 27 days ago - CG Oncology Earnings release: Q2 2026 - Filings
- 27 days ago - CG Oncology Quarterly report: Q2 2026 - Filings
- 27 days ago - CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 weeks ago - CG Oncology announces publication of BOND-003 results in The Lancet Oncology - TheFly